Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GNMSF) EBIT Margin (2024 - 2025)

Historic EBIT Margin for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to 5.48%.

  • Genmab A's EBIT Margin fell 281000.0% to 5.48% in Q4 2025 from the same period last year, while for Dec 2025 it was 28.63%, marking a year-over-year decrease of 25100.0%. This contributed to the annual value of 28.63% for FY2025, which is 25100.0% down from last year.
  • According to the latest figures from Q4 2025, Genmab A's EBIT Margin is 5.48%, which was down 281000.0% from 44.91% recorded in Q3 2025.
  • Genmab A's EBIT Margin's 5-year high stood at 44.91% during Q3 2025, with a 5-year trough of 5.48% in Q4 2025.